For people with diabetes, the feet represent an area of particular vulnerability.
In fact, podiatric disorders rank among the leading causes of severe complications and hospitalization.
The most common manifestations of the diabetic foot include the development of skin ulcers, the onset of infections, and osteoarticular deformities.
Early adoption of a targeted protocol can significantly reduce the incidence and severity of these complications.
Individuals with peripheral neuropathy, vascular insufficiency, joint stiffness or callosities are considered to be at higher risk and require closer monitoring.
Our product Xerem, available in cream and spray lotion, is the result of rigorous scientific research and careful selection of active substances and is a concrete support as an approach to the diabetic foot problem.
